Denali Therapeutics Inc (DNLI)
20.48
-0.25
(-1.21%)
USD |
NASDAQ |
Jun 17, 16:00
20.64
+0.16
(+0.78%)
After-Hours: 20:00
Denali Therapeutics Cash and Short Term Investments (Quarterly): 936.87M for March 31, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 936.87M |
December 31, 2023 | 1.035B |
September 30, 2023 | 1.109B |
June 30, 2023 | 1.191B |
March 31, 2023 | 1.288B |
December 31, 2022 | 1.336B |
September 30, 2022 | 1.106B |
June 30, 2022 | 1.069B |
March 31, 2022 | 957.52M |
December 31, 2021 | 865.41M |
September 30, 2021 | 1.039B |
June 30, 2021 | 1.309B |
March 31, 2021 | 1.413B |
December 31, 2020 | 1.470B |
Date | Value |
---|---|
September 30, 2020 | 961.20M |
June 30, 2020 | 549.58M |
March 31, 2020 | 587.25M |
December 31, 2019 | 415.36M |
September 30, 2019 | 479.39M |
June 30, 2019 | 478.60M |
March 31, 2019 | 485.48M |
December 31, 2018 | 464.30M |
September 30, 2018 | 374.96M |
June 30, 2018 | 372.59M |
March 31, 2018 | 373.40M |
December 31, 2017 | 406.23M |
September 30, 2017 | 185.80M |
December 31, 2016 | 178.33M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
415.36M
Minimum
Dec 2019
1.470B
Maximum
Dec 2020
979.81M
Average
1.037B
Median
Cash and Short Term Investments (Quarterly) Benchmarks
Halozyme Therapeutics Inc | 463.45M |
Neurocrine Biosciences Inc | 1.211B |
AIM ImmunoTech Inc | 10.94M |
Protalix BioTherapeutics Inc | 48.49M |
Armata Pharmaceuticals Inc | 37.86M |